PharmExec
MAY 22, 2023
The market for prescription medicines in the United States was subject to major shifts in use across therapeutic areas in 2022, reflecting changes in patient health needs, the development, and availability of novel medicines, and complex market dynamics.
STAT
MAY 23, 2023
In 2023, just under 2 million Americans will be diagnosed with cancer. Many will endure multiple CT and MRI studies and intensive medical care, including surgery, radiation, chemotherapy, or immunotherapy. Fortunately, advances in treatment and novel therapies have steadily improved survival following a cancer diagnosis. Cancer death rates have declined by 27% over the past 20 years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PhRMA
MAY 1, 2023
The Pharmaceutical Research and Manufacturers of America (PhRMA) today launched a new ad campaign that continues to shed light on the role of pharmacy benefit managers (PBMs) in driving up health care costs and denying coverage of lifesaving medicines.
Pharmacy Is Right For Me
MAY 22, 2023
Jamila Jorden, a pharmacist and academic advisor, recently gave an interview discussing the multifaceted role of pharmacists. She also discussed the importance of experiential education in preparing pharmacy students for their careers. Jamila’s experiences in the pharmacy profession provide valuable insight into the varied roles and responsibilities of pharmacists.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MAY 19, 2023
Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.
Pharmacy Times
MAY 1, 2023
Analysis shows that the ratio of neutralizing antibody geometric mean titers in adolescents compared with young adults was 1.5 after vaccination with NVX-CoV2373.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MAY 24, 2023
Over the last few years, Daniel Cleggett Jr. appeared to be living a charmed life. The founder of a small Boston-area addiction treatment empire knew he was under scrutiny; the Globe and STAT News published investigations in 2017 and 2019 into his questionable business dealings, and the Massachusetts attorney general’s office announced shortly after that it was examining alleged scams involving addiction treatment.
PhRMA
MAY 1, 2023
Too many Americans are struggling to access and afford their health care. While policy debates about how to address these issues can seem never ending, American adults largely agree on what state policymakers should be doing to help deliver relief to patients at the pharmacy counter.
Fierce Healthcare
MAY 25, 2023
Employers face soaring demand for obesity care benefits.
Drug Topics
MAY 30, 2023
Part of the risk of developing kidney involvement begins when type 1 diabetes mellitus (T1DM) sets in and establishes itself in the patient, with up to 65% of children experiencing acute kidney injury during T1DM onset, which can further predispose to the development of future chronic kidney disease.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
MAY 12, 2023
BI 456906 activates the GLP-1 and glucagon receptors that help to control metabolic function, and could potentially offer clinically relevant benefits for those living with obesity or overweight without type 2 diabetes.
Fierce Pharma
MAY 19, 2023
Krystal's Vyjuvek becomes first topical gene therapy with FDA nod to treat rare skin disease zbecker Fri, 05/19/2023 - 16:25
STAT
MAY 15, 2023
When gastroenterologists learned in March that UnitedHealthcare plans to barricade many colonoscopies behind a controversial and complicated process known as prior authorization, their emotions cycled rapidly between fear, shock, and outrage. The change, which the health insurer will implement on June 1, means that any United member seeking surveillance and diagnostic colonoscopies to detect cancer will first need approval from United — or else have to pay out of pocket.
PhRMA
MAY 30, 2023
As we recognize Mental Health Awareness Month, I had the opportunity to connect with PhRMA board member Barry Greene, CEO of Sage Therapeutics, about the company’s efforts to address mental health.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
MAY 8, 2023
UnitedHealth extends its hot streak as the most profitable payer in Q1 pminemyer Mon, 05/08/2023 - 13:28
Drug Topics
MAY 25, 2023
A short supply of cisplatin and carboplatin is forcing health care providers to find less effective alternative treatments.
Pharmacy Times
MAY 11, 2023
Tackling racial disparities among health care providers can help improve disparities faced by patients.
Fierce Pharma
MAY 22, 2023
Blueprint's Ayvakit picks up long-awaited FDA approval in indolent systemic mastocytosis zbecker Mon, 05/22/2023 - 14:43
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MAY 5, 2023
A new study sheds light on what may be causing very rare cases of heart inflammation in young men after receiving an mRNA Covid vaccine. Early hypotheses as to what was driving the heart inflammation, called myocarditis , included an allergic response to the vaccine, vaccine-induced antibodies, or an autoimmune response in which the immune system attacks the body’s own healthy tissue by mistake.
PhRMA
MAY 8, 2023
Indiana just joined West Virginia and Arkansas in delivering an important win for Hoosiers who are struggling to afford their medicines. This week, Governor Holcomb signed into law Senate Bill 8 recently passed by the Indiana legislature. This new law will ensure that Indiana patients aren’t paying more for their medicines than their health insurance company or the middlemen known as pharmacy benefit managers (PBMs).
Fierce Healthcare
MAY 16, 2023
Kaiser Permanente discloses timeline, financial commitments for its VBC megadeal with Geisinger Health dmuoio Tue, 05/16/2023 - 12:40
Drug Topics
MAY 24, 2023
Data presented at Digestive Disease Week show that patients with IBD had less intense post-vaccination symptoms after a fourth dose.
Pharmacy Times
MAY 23, 2023
In neonatal intensive care units, probiotic usage was associated with a decline in necrotizing enterocolitis, but not with sepsis or mortality rates.
Fierce Pharma
MAY 31, 2023
FDA warns patients about compounded versions of Novo Nordisk's Ozempic, Wegovy kdunleavy Wed, 05/31/2023 - 13:02
STAT
MAY 8, 2023
“S o, you don’t have it in liquid form?” I asked. The answer, as usual, was no. I hung up the phone and sighed.
PhRMA
MAY 4, 2023
When it comes to health care, Americans are concerned about innovation and affordability.
Fierce Healthcare
MAY 15, 2023
PBGH: What employers want to see as Congress aims to reform PBMs pminemyer Mon, 05/15/2023 - 16:13
Drug Topics
MAY 19, 2023
Your weekly roundup of the latest news from Drug Topics®.
Pharmacy Times
MAY 26, 2023
With so many radical developments in medicine and technology unfolding at once, the role and potential of the pharmacy as we know it is evolving at breakneck speed.
Pharmaceutical Technology
MAY 11, 2023
Results published in Nature for a personalised pancreatic cancer vaccine that uses neoantigens from patients’ tumours have lent further support to early positive signals. The vaccine, developed by BioNTech, led to half of the patients with pancreatic cancer in the Phase I trial remaining cancer-free 18 months later. In the study, 16 patients were treated with a vaccine called autogene cevumeran that contained a maximum of 20 neoantigens, alongside Roche’s anti-PD-L1 immunotherapy Tecentriq (atez
STAT
MAY 19, 2023
A defanged form of CRISPR, which doesn’t slice or nick DNA, but rather alters the epigenome — the layers of chemical coding that sit on top of DNA and control the activity of genes — has aced its first substantive test. When researchers used CRISPR “ epigenome editing ” to dial down a cholesterol-associated gene in monkeys, the animals’ blood levels of heart-disease-causing LDL, or “bad” cholesterol, plummeted by more than 50%, Jennifer Kwo
PhRMA
MAY 9, 2023
This week, policymakers on Capitol Hill will continue to discuss the cost of lifesaving medicines and how to make them more affordable for Americans. It’s an important discussion that the biopharmaceutical industry believes we need to have. A new treatment or cure can’t improve a patient’s life if they can’t get it. As the conversation continues in Congress, IQVIA is out with a new and timely report on medicine prices and spending.
Fierce Healthcare
MAY 11, 2023
Industry Voices—Where we go from here: Community pharmacy in a post-pandemic world pminemyer Thu, 05/11/2023 - 14:47
Expert insights. Personalized for you.
111 
Let's personalize your content